Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitorsWataru Fukuokaya, Shin Egawa, Takahiro Kimura et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 24
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter studyFumihiko Urabe, Takahiro Kimura, Masaya Murakami et al.|Japanese Journal of Clinical Oncology|2024Cited by 22
Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter studyFumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa et al.|International Journal of Urology|2024Cited by 20
Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective studyKazuhiro Takahashi, Takahiro Kimura, Fumihiko Urabe et al.|Japanese Journal of Clinical Oncology|2023Cited by 13
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter studyFumihiko Urabe, Takahiro Kimura, Keiichiro Mori et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 11